We Expect WuXi Biologics' Growth to Lag Peers
We forecast WuXi's revenue growth to be slower than that of other well-established peers. The risk is high that the US Biosecure Act will become law, and we expect global pharmaceutical or ...
Fierce Pharma6d
Contractors WuXi Bio, WuXi XDC eye continued growth after logging solid performances in 2024
Shortly after WuXi AppTec provided an upbeat outlook for 2025, several other WuXi sibling companies are coming forward with ...
Chinese stocks close at three-month high, leading gains in Asia, despite fall on Wall Street
Asia-Pacific markets mostly rose on Friday despite a plunge in all three benchmarks in the U.S. over the previous session ...
NBC 7 San Diego18d
Chinese stocks close at three-month high, leading gains in Asia, despite fall on Wall Street
This is CNBC's live blog covering Asia-Pacific markets. Asia-Pacific markets mostly rose on Friday despite a plunge in all three benchmarks in the U.S. over the previous session amid concern about ...